| Description |
1 electronic text (107 pages) : color illustrations, digital file |
| Series |
The Future Science Group eBook collection, 2047-332X |
|
Future Science Group eBook collection, 2047-332X
|
| Contents |
Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / Jan B. Vermorken -- Colorectal cancer / Christian Rolfo, Giuseppe Bronte, Antonio Russo & Marc Peeters -- Breast cancer / Sevilay Altintas -- Lung cancer and genitourinary cancers / Dirk Schrijvers -- Tumors of the skin, the CNS and the head and neck / Pol Specenier -- Gynecologic cancers / Jan B. Vermorken -- Index |
| Summary |
This book focuses on mAbs targeting EGFR and HER2 and, in five chapters, summarizes information on the use of these mAbs in colorectal cancer, breast cancer, lung cancer, genitourinary cancers, tumors of the skin, the CNS and the head and neck, and gynecologic malignancies |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Title from PDF title page (Future Medicine eBooks Web site, viewed June 28, 2013) |
|
Also available in print |
| Subject |
Monoclonal antibodies -- Therapeutic use
|
|
HER-2 gene.
|
|
HER-2 protein.
|
|
Epidermal growth factor.
|
|
Cancer -- Chemotherapy.
|
|
Antibodies, Monoclonal -- therapeutic use
|
|
ErbB Receptors
|
|
Neoplasms -- drug therapy
|
|
Receptor, ErbB-2
|
|
Genes, erbB-2
|
|
Epidermal Growth Factor
|
|
Cancer -- Chemotherapy
|
|
Epidermal growth factor
|
|
HER-2 gene
|
|
HER-2 protein
|
|
Monoclonal antibodies -- Therapeutic use
|
| Form |
Electronic book
|
| Author |
Vermorken, Jan B
|
|
Future Medicine Ltd
|
| ISBN |
9781780843278 |
|
1780843275 |
|
9781780843285 |
|
1780843283 |
|
